
Dec 23 (Reuters) - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
The individual died on December 14 after suffering a stroke followed by a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.
The patient was enrolled in a study that was testing Hympavzi in patients with hemophilia A or B with or without inhibitors.
"Pfizer, together with the trial investigator and the independent external Data Monitoring Committee, are actively gathering information to better understand the complex, multi-factorial circumstances surrounding this occurrence," the company said in a statement.
The therapy, a once-a-week injection, gained U.S. approval last year to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older by targeting blood-clotting proteins.
Pfizer does not anticipate any impact to safety for patients treated with the drug based on its current knowledge and the overall clinical data collected to date, the company said.
People with hemophilia have a defect in a gene that regulates the production of proteins called clotting factors, causing spontaneous and severe bleeding following injuries or surgery.
Earlier this year, Pfizer said it would halt global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors.
Beqvez, a one-time therapy, was approved in the U.S. for the treatment of adults with moderate to severe hemophilia B.
(Reporting by Sneha S K in Bengaluru; Editing by Anil D'Silva)
LATEST POSTS
- 1
Germany paves the way for tighter EU asylum rules - 2
Bitcoin momentum builds in Abu Dhabi as global interest surges - 3
Vote in favor of your Number one Kind of Shades - 4
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - 5
$1,000 bribes, Mormon momfluencer mixers and making content to get plastic surgery: The wildest things I learned reporting my book
The Iran war’s energy security legacy
Cyber Monday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
Language Learning Stages: Which One Gets Your Vote?
After toilet and email issues, Artemis II astronauts fire engine to head for the moon
Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
Consumer outlook on UK economy falls to two-year low
Must-Have Cooking Machine in Your Kitchen
Germany's Merz under fire in Brazil for his comments on Amazon host city of COP30
NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says













